Scientists Discover New Cure for the Deadliest Strain of Tuberculosis

This article describes the recent FDA approval of the anti-TB agent pretomanid, and it’s use in a novel regimen that is saving lives of multiply-drug resistant (MDR) TB patients in South Africa. Department of Microbiology Professor and Chair David Sherman played a major role in the early stage development of pretomanid.

Publication Date: 

Tuesday, August 20, 2019